VeriMomapium graveolens seed extract hamilelikte güvenli mi?
No evidence found of EU cosmetic bans/restrictions (Annex II/III) or harmonised reproductive hazard classification for Apium graveolens seed extract (CAS 89997-35-3). Cosmetic databases list the INCI (CosIng) and EWG lists the ingredient but do not flag reproductive toxicity. Peer-reviewed studies on major celery seed constituents (e.g., 3‑n‑butylphthalide) report pharmacology/toxicity data after oral dosing but do not support a confirmed reproductive teratogen classification; therefore hazard (h)=0 and mechanism (m)=0. Topical exposure has low but measurable absorption potential (botanical volatiles/constituents), so exposure (e)=1 for pregnancy (adult topical use). Sources: CosIng entry, EWG entry, PubMed pharmacology/toxicity studies, supplier/CAS listings.
Pregnancy-safe products containing apium graveolens seed extract
Related ingredients
Frequently asked questions
- apium graveolens seed extract hamilelikte güvenli mi?
- No evidence found of EU cosmetic bans/restrictions (Annex II/III) or harmonised reproductive hazard classification for Apium graveolens seed extract (CAS 89997-35-3). Cosmetic databases list the INCI (CosIng) and EWG lists the ingredient but do not flag reproductive toxicity. Peer-reviewed studies on major celery seed constituents (e.g., 3‑n‑butylphthalide) report pharmacology/toxicity data after oral dosing but do not support a confirmed reproductive teratogen classification; therefore hazard (h)=0 and mechanism (m)=0. Topical exposure has low but measurable absorption potential (botanical volatiles/constituents), so exposure (e)=1 for pregnancy (adult topical use). Sources: CosIng entry, EWG entry, PubMed pharmacology/toxicity studies, supplier/CAS listings.
- apium graveolens seed extract emzirirken güvenli mi?
- No specific data indicating reproductive or lactation/transfer hazards; no harmonised H361/H360 or EU Annex II/III listing. Mechanistic data for placental/milk transfer are lacking; topical exposure to breastfeeding parent is therefore low but measurable (e=1). Same rationale as pregnancy.
- apium graveolens seed extract bebek cildi için güvenli mi?
- No infant-specific reproductive or developmental toxicity data found for topical Apium graveolens seed extract. Because infant skin (0–3 yr) has higher absorption/surface‑area‑to‑weight and the ingredient can contain lipophilic/volatile constituents, I increase exposure score by +1 relative to adults (adult e=1 → infant e=2). No evidence found that justifies increasing hazard (h) or mechanism (m) for infants.
- VeriMom apium graveolens seed extract nasıl puanlıyor?
- VeriMom apium graveolens seed extract'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte apium graveolens seed extract yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.